Ionis Pharmaceuticals Inc (NASDAQ:IONS)

43.48
Delayed Data
As of Apr 26
 -0.50 / -1.14%
Today’s Change
40.33
Today|||52-Week Range
65.51
-13.56%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 60.50, with a high estimate of 106.00 and a low estimate of 34.00. The median estimate represents a +39.14% increase from the last price of 43.48.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in Ionis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.02
Sales
$108.1M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.50%
 
 
 
 
 
 
Growthannually -504.09%
 
 
 
 
 
 

Sales

Growthquarterly -37.27%
 
 
 
 
 
 
Growthannually 18.74%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.